Disclosure Panels Details Page
Thyroid Carcinoma Panel - Disclosures as of 10/29/2018
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Marian Birkeland PhD | None | None | None | None | - |
| Lindsay Bischoff MD | None | None | None | None | ✔ |
| Naifa Busaidy MD, FACP | Eisai Inc. GlaxoSmithKline Novartis Pharmaceuticals Corporation |
Eisai Inc. | None | None | - |
| Glenda Callender MD, FACS | None | None | None | None | - |
| Sarah DeVincenzo PharmD, BCPS | None | Decision Resources Group Consulting | None | None | - |
| Paxton Dickson MD | None | None | None | None | - |
| Quan-Yang Duh MD | None | None | None | None | - |
| Hormoz Ehya MD | None | None | None | None | ✔ |
| Whitney Goldner MD | Eisai Inc. Roche Laboratories, Inc. |
None | None | None | ✔ |
| Kristina Gregory MSN, RN, OCN | None | None | None | None | - |
| Lisa Gurski PhD | None | None | None | None | ✔ |
| Robert Haddad MD | Bristol-Myers Squibb Company Genentech, Inc. Merck & Co., Inc. Pfizer Inc. |
AstraZeneca Pharmaceuticals LP Bristol-Myers Squibb Company Celgene Corporation Eisai Inc. Genentech, Inc. Merck & Co., Inc. Pfizer Inc. |
None | None | ✔ |
| Evelyn Handel PharmD, BCOP, BCPS | None | None | None | None | - |
| Megan Haymart MD | None | None | None | None | ✔ |
| Carl Hoh MD | None | None | None | None | - |
| Jason Hunt MD | None | None | None | None | - |
| Andrei Iagaru MD | None | None | None | None | ✔ |
| Alyse Johnson-Chilla MS | None | None | None | None | ✔ |
| Fouad Kandeel MD, PhD | None | None | None | None | - |
| Ann Karosas RPh, BCOP | None | None | None | None | - |
| Peter Kopp MD | None | None | None | American Thyroid Association|Editor in Chief: Thyroid. Official Journal American Thyroid Association | - |
| Dominick Lamonica MD | None | None | None | None | ✔ |
| Bryan McIver MD, PhD | None | None | None | None | - |
| Sharon Park PharmD, BCOP | None | None | None | None | ✔ |
| Donna Powell DHSc, CMD, RT(T) | None | None | None | None | ✔ |
| Christopher Raeburn MD | None | None | None | None | ✔ |
| John Ridge MD, PhD, FACS | None | None | None | None | ✔ |
| Matthew Ringel MD | Syros Pharmaceuticals | None | None | None | ✔ |
| Mara Roth MD | NA | NA | NA | NA | ✔ |
| Randall Scheri MD | None | None | None | None | - |
| Jatin Shah MD, PhD | None | None | None | None | - |
| Rebecca Sippel MD | National Cancer Institute | None | None | None | - |
| Jack Skinner PhD | None | None | None | None | ✔ |
| Robert Smallridge MD | None | None | None | None | - |
| Cord Sturgeon MD | None | None | Osler Institutue | None | - |
| Erin Vidic | None | None | None | None | - |
| Thomas Wang MD, PhD | None | None | None | None | - |
| Lori Wirth MD | None | Ayala Bayer HealthCare Eisai Inc. Loxo Merck & Co., Inc. |
None | None | ✔ |
| Richard Wong MD, FACS | None | None | None | None | ✔ |